Rivastigmine Transdermal Patches Bioequivalence and Adhesion Assessment
Clinical trial NCT07464340 · COMPLETED
Trial details
- NCT number
- NCT07464340
- Sponsor
- Zodiac Produtos Farmaceuticos S.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-12
- Primary completion
- 2023-06-06
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.